vimarsana.com
Home
Live Updates
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR : vimarsana.com
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
TScan’s abstract selected by the Tandem Meetings to receive a Best Abstracts Award Company to discuss the potential implications of initial data from a large prospective clinical trial assessing...
Related Keywords
United States ,
American ,
Shrikanta Chattopadhyay ,
Monzrm Al Malki ,
Joyce Allaire ,
Debora Barton ,
Gavin Macbeath ,
Heather Savelle ,
International Blood ,
Tscan Therapeutics Inc ,
Nasdaq ,
Marrow Transplant Research ,
Securities Exchange ,
Lifesci Advisors ,
Department Of Hematology Hematopoietic Cell Transplantation ,
Globe Newswire Tscan Therapeutics Inc ,
Tandem Meetings ,
Best Abstracts ,
Cellular Therapy Meetings ,
American Society ,
Cellular Therapy ,
Associate Professor ,
Hematopoietic Cell Transplantation ,
Unrelated Donor Bone Marrow Transplant ,
Haploidentical Transplant Programs ,
Columbia University Irving Medical ,
Chief Executive Officer ,
Chief Medical Officer ,
Senior Vice President ,
Translational Medicine ,
Private Securities Litigation Reform Act ,
Securities Exchange Act ,
Financial Condition ,
Annual Report ,
Sci Advisors ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.